SCHEMBL6007222

SCHEMBL6007222

O=S(=O)(NC(CCN1CCC(Cc2ccccc2)CC1)c1ccccc1)c1cccs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 1/20 0.56
POLB P06746 1/20 0.56
TSHR P16473 1/20 0.56
MAPK1 P28482 1/20 0.56
KMT2A Q03164 1/20 0.56
CCR5 P51681 2/20 0.52
SLC6A2 P23975 2/20 0.47
SLC6A3 Q01959 2/20 0.47
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47
HTR1A P08908 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448769 0.85 SLC6A2 (0.53) MEN1KMT2ACCR5SLC6A2SLC6A3
SCHEMBL6008053 0.82 SLC6A2 (0.54) MEN1KMT2ACCR5SLC6A2SLC6A3
SCHEMBL6007229 0.81 KDM4E (0.56) MEN1MAPK1KMT2ACCR5SLC6A2
SCHEMBL5466311 0.78 CCR5 (0.43) ALDH1A1MEN1KMT2ACCR5HTR1A
SCHEMBL5453970 0.78 CCR5 (0.46) CCR5
SCHEMBL6009357 0.78 TMEM97 (0.47) MEN1POLBKMT2ASLC6A2SLC6A3
SCHEMBL6008682 0.78 OPRM1 (0.46) CCR5SLC6A2SLC6A3GRIN2DGRIN3B
SCHEMBL5466360 0.76 CCR5 (0.40) ALDH1A1MEN1KMT2ACCR5HTR1A
SCHEMBL5466362 0.76 CCR5 (0.40) ALDH1A1MEN1KMT2ACCR5HTR1A
SCHEMBL5758217 0.76 ALDH1A1 (0.56) ALDH1A1MEN1POLBTSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US claimed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US claimed
US-7078537-B2 Phenylalkyl diamine and amide analogs SK CORPORATION (KR) 2006-07-18 US disclosed
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SK BIOPHARMACEUTICALS CO., LTD. (KR) 2003-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030105079-A1 Novel phenylalkyl diamine and amide analogs SIGMAR1, TAAR1, OPRL1 ALDH1A1 639/4885MEN1 4634/4885POLB 2456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.